Extracorporeal Membrane Oxygenation (ECMO) is emergently used for long-term support of respiratory and/or cardiac functions. ECMO is most useful in cases when the primary lung insult is reversible. CESAR trial in 2009 showed survival benefits in severe ARDS patients when transferred to an ECMO center compared to those receiving standard care in their ICU.
Introduction
Extracorporeal Membrane Oxygenation (ECMO) is used for respiratory function support. It is indicated for patients with severe ventilation and/or oxygenation failure who are unlikely to survive conventional lung protective mechanical ventilation [1, 2] . ECMO is most useful when the primary lung insult is thought to be reversible [3] .
Organophosphate (OP) compounds are diverse groups of chemicals used in both domestic and industrial settings [4] . These compounds are still used in different forms in developing countries in domestic uses [4] . It can affect respiratory system through causing: rhinorrhea, bronchorrhea, bronchospasm, cough, and severe respiratory distress. Respiratory failure and adult respiratory distress syndrome (ARDS) are the most life-threatening sequelae and require immediate intervention [5, 6] .
We here discuss a case report of a patient presented to our center after accidental ingestion of one of these compounds leading to development of severe ARDS.
Case report
A 14 year old female patient, actual body weight 50 kg with no relevant past medical history, presented to KasrEl-Ainy Toxicology Center, Cairo university, with a history of accidental ingestion of an organophosphorus compound (Chlorpyrifos). Routine management was initiated there in the form of general supportive measures, atropine and neostigmine. Two days after admission she complained of increasing respiratory distress coinciding with progressive hypoxemia and the appearance of bilateral lung infiltrates on CXR and CT chest ( Fig. 1) .
She was invasively ventilated on lung protective strategy using low tidal volume of 6 ml/kg, PEEP of 14 cm H 2 O and an FiO 2 of 1, on an assisted volume control mode. She had an event of cardiac arrest in bradycardia that happened with progressive unresponsive hypoxia with successful resuscitation.
She was transferred to our center for the possibility of ECMO. When admitted she was sedated with propofol 0.05 mg/kg/min, paralyzed with atracurium 10 mcg/kg/min and maintained on vasopressors noradrenalin 0.1 lg/kg/min with her hemodynamic profile showing blood pressure 132/83 mmHg, heart rate 135 beat/min, temperature 36.8°C and central venous pressure 8 cm H 2 O. With sedation vacation, she regained consciousness after the cardiac arrest event.
Arterial blood gases showed pH 7.29, PCO 2 55 mmHg, PO 2 55 mmHg, HCO 3 26 mEq/L and O 2 Saturation of 75%. Prone positioning was tried with no improvement in oxygenation.
Murray Lung Injury Score was 3.25, PaO 2 /FIO 2 ratio was 55, 3 quadrants affected in CXR, PEEP of 14 cm H 2 O and lung compliance was 23 ml/cm H 2 O.
Laboratory profile showed normal serum electrolytes and renal function. She was severely anemic with a hemoglobin level of 6.8 gm/dl, for which three units of packed RBCs were given. Cholinesterase level was almost not detected supporting the diagnosis of OP poisoning, H1N1 screen was negative, sputum and blood culture that yielded no growth.
Decisions were taken to initiate veno-venous (V-V) ECMO after taking the father's consent. Percutaneous cannulation was done via femoro-atrial approach using drainage right femoral Maquet cannula (23 f/38 cm) and return right internal jugular Maquet cannula (21 f/23 cm) and the cannula positions were verified with CXR and ultrasonography (Fig. 2) . Rotaflow console from Maquet was used.
The patient RESP score [7] was 0 correlating with a survival of 40-60%. The flow during the first 24 h ranged from 80 to 100 ml/kg/min. Mechanical ventilation during ECMO was on assisted pressure controlled ventilation with peak inspiratory pressure of 15 cm H 2 O, PEEP 10 cm H 2 O and FiO 2 40% resulting in a tidal volume of 60-80 ml.
Anticoagulation using unfractionated heparin infusion was initiated, target a Partial Thromboplastin time (PTT) of 50-60 ms.
The ECMO run duration was 6 days. On day 5 there was dramatic improvement in oxygenation PaO 2 /FIO 2 reached 250, lung compliance 55 ml/cm H 2 O and that was coinciding with significant improvement of CXR ( Fig. 3a and b) .
Successful decannulation was done after weaning from ECMO on day 6 by decreasing FiO 2 on ECMO while contin- uing on pressure support ventilation. Successful extubation was done after 2 days of ECMO decannulation.
The patient suffered from difficulty in swallowing as a residual nicotinic effect of OP poisoning that improved over several days. Mood changes and post-traumatic stress disorder were other consequences that were followed up on outpatient basis with neuro-psychiatry consultants.
Discussion
This is a case fulfilling the criteria of severe ARDS after OP poisoning. Diagnosis of OP poisoning was done by history of ingestion, and confirmed with cholinesterase level and absence of causative organism in cultures.
Organophosphorus poisoning is a very common problem in developing countries and is a major problem in south west Asia specially India. There are several case reports and papers that discussed this problem [8] [9] [10] . The main treatment is atro-pine in large doses to compete with acetylcholine on muscarinic acetylcholine receptors thus decreasing the cholinergic crisis manifestations. In our case the patient presented to the toxicology hospital in respiratory arrest, she was successfully resuscitated and atropine was given repeatedly until dilatation of her pupils. The mechanism of ARDS in organophosphorus poisoning may be attributed to be a complication of aspiration and super added acquired infection. We believe aspiration and consequent ARDS were the scenario in our patient. Lainee et al. animal studies showed that intravenous injection of organophosphorus compounds in dogs initiated ARDS through breakdown of alveolar/endothelial barrier and inflammatory/exudative infiltrates into the lungs within two hours [11, 12] . These cases could benefit from V-V ECMO support according to the ELSO guidelines especially in the presence of a totally reversible cause as OP poisoning. Mechanical ventilation less than 7 days before ECMO carries a favorable outcome [13, 14] . There are many case reports about OP induced respiratory failure that required mechanical ventilation as a solution for respiratory failure but no cases with ECMO was shown to be published to our knowledge. Mechanical ventilation was initiated in our case before ECMO for respiratory support but it failed to maintain adequate oxygenation.
In previous ECMO studies and similarly in our case V-V femoro-jugular percutaneous cannulation approach was shown to be better than other approaches since less pump flow is needed to achieve the same oxygenation [15] .
Weaning from V-V ECMO in our case is done through keeping same flow to avoid oxygenator thrombosis followed by decreasing ECMO FIO 2 over 24 h then decannulation if we have satisfactory blood gases on low requirement mechanical ventilation [16] .
As regards the neurological, post-traumatic stress disorder and depression are common in survivors of ARDS a condition which may persist for years as mentioned in the study by Kapfhammer et al. in 2004 [17] .
Conclusion
ECMO can be successfully used in treatment of ARDS, especially, when due to reversible causes as OP poisoning. 
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